KONINKLIJKE PHILIPS NV (1PHIA.MI) Stock Fundamental Analysis
BIT:1PHIA - Euronext Milan - NL0000009538 - Common Stock - Currency: EUR
Overall 1PHIA gets a fundamental rating of 3 out of 10. We evaluated 1PHIA against 58 industry peers in the Health Care Equipment & Supplies industry. 1PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. 1PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1PHIA was profitable.
In multiple years 1PHIA reported negative net income over the last 5 years.
1PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
1PHIA has a Return On Assets (1.37%) which is comparable to the rest of the industry.
The Return On Equity of 1PHIA (3.19%) is comparable to the rest of the industry.
1PHIA has a Return On Invested Capital (3.56%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 3.19% | ||
| ROIC | 3.56% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
1PHIA has a Profit Margin (2.07%) which is in line with its industry peers.
The Operating Margin of 1PHIA (5.39%) is comparable to the rest of the industry.
1PHIA's Operating Margin has declined in the last couple of years.
The Gross Margin of 1PHIA (43.42%) is worse than 67.24% of its industry peers.
1PHIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.39% | ||
| PM (TTM) | 2.07% | ||
| GM | 43.42% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1PHIA is destroying value.
The number of shares outstanding for 1PHIA has been reduced compared to 1 year ago.
Compared to 5 years ago, 1PHIA has more shares outstanding
Compared to 1 year ago, 1PHIA has a worse debt to assets ratio.
2.2 Solvency
1PHIA has an Altman-Z score of 1.81. This is a bad value and indicates that 1PHIA is not financially healthy and even has some risk of bankruptcy.
1PHIA has a Altman-Z score of 1.81. This is comparable to the rest of the industry: 1PHIA outperforms 44.83% of its industry peers.
1PHIA has a Debt/Equity ratio of 0.60. This is a neutral value indicating 1PHIA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, 1PHIA is doing worse than 65.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.81 |
ROIC/WACC0.58
WACC6.17%
2.3 Liquidity
A Current Ratio of 1.28 indicates that 1PHIA should not have too much problems paying its short term obligations.
The Current ratio of 1PHIA (1.28) is worse than 62.07% of its industry peers.
A Quick Ratio of 0.79 indicates that 1PHIA may have some problems paying its short term obligations.
1PHIA has a Quick ratio of 0.79. This is in the lower half of the industry: 1PHIA underperforms 63.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
1PHIA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.45%.
Measured over the past years, 1PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
Looking at the last year, 1PHIA shows a decrease in Revenue. The Revenue has decreased by -0.89% in the last year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)7.45%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-3.85%
Revenue 1Y (TTM)-0.89%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.99%
3.2 Future
Based on estimates for the next years, 1PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.40% on average per year.
Based on estimates for the next years, 1PHIA will show a small growth in Revenue. The Revenue will grow by 3.10% on average per year.
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.4%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.1%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.89, which indicates a correct valuation of 1PHIA.
Compared to the rest of the industry, the Price/Earnings ratio of 1PHIA indicates a rather cheap valuation: 1PHIA is cheaper than 94.83% of the companies listed in the same industry.
1PHIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.98.
Based on the Price/Forward Earnings ratio of 11.92, the valuation of 1PHIA can be described as reasonable.
87.93% of the companies in the same industry are more expensive than 1PHIA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, 1PHIA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.89 | ||
| Fwd PE | 11.92 |
4.2 Price Multiples
1PHIA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1PHIA is cheaper than 82.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.89 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1PHIA's earnings are expected to grow with 12.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.5
PEG (5Y)N/A
EPS Next 2Y11.54%
EPS Next 3Y12.13%
5. Dividend
5.1 Amount
1PHIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1PHIA (6/26/2025, 7:00:00 PM)
20.55
+0.98 (+5.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners42.8%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap19.32B
Analysts72
Price Target26.09 (26.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.27%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.14%
Min EPS beat(2)-11.97%
Max EPS beat(2)22.24%
EPS beat(4)1
Avg EPS beat(4)-3.31%
Min EPS beat(4)-16.56%
Max EPS beat(4)22.24%
EPS beat(8)2
Avg EPS beat(8)-6.4%
EPS beat(12)4
Avg EPS beat(12)8.51%
EPS beat(16)5
Avg EPS beat(16)1.66%
Revenue beat(2)0
Avg Revenue beat(2)-2.5%
Min Revenue beat(2)-3.04%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.17%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.16%
Revenue beat(12)2
Avg Revenue beat(12)-1.77%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-8.75%
PT rev (3m)-9.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.95%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.89 | ||
| Fwd PE | 11.92 | ||
| P/S | 1.07 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.65 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.89 |
EPS(TTM)1.38
EY6.72%
EPS(NY)1.72
Fwd EY8.39%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS19.13
BVpS12.44
TBVpS-1.36
PEG (NY)1.5
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 3.19% | ||
| ROCE | 4.75% | ||
| ROIC | 3.56% | ||
| ROICexc | 3.78% | ||
| ROICexgc | 11.65% | ||
| OM | 5.39% | ||
| PM (TTM) | 2.07% | ||
| GM | 43.42% | ||
| FCFM | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.99 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 1.81 |
F-ScoreN/A
WACC6.17%
ROIC/WACC0.58
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.45%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-3.85%
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.4%
Revenue 1Y (TTM)-0.89%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.99%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.1%
EBIT growth 1Y379.25%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.08%
EBIT Next 3Y20.59%
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%